IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
The Effect of Economic Sanctions on Treatment of Thalassemia Major Referring to Selected Medical Centers in Fars Province

Author: ASLANI MARZIEH, FATEMEH BAYAT SHAHPARAST, HOSSEINIZEIDABADI SEPIDEHSADAT, NAZARIDOUST TAYEBEH, KHALIL ABBASI
Abstract: Background: In the list of sanctions, as a destructive political tool against some countries, drug trade is not officially prohibited, but according to existing reports, patients in sanctioned countries are having difficulty obtaining the drugs they need in practice. The purpose of this study was to investigate the effect of US and EU economic sanctions against Iran on the treatment of thalassemia major patients in Iran. Methods: To achieve the objectives of the study, 249 major thalassemia patients referred to five treatment centers in Fars province (August, 2019), who were treated with Deferasirox oral medications (Osveral or Exjade) and injectable forms (desferal), were studied and the type of medication used, their access to these drugs, and serum ferritin levels before and one year after the last economic sanction, were recorded in a Demographic information form. Data were analyzed by SPSS software using Kappa coefficient. Results: The results of the study showed that after the latest Iranian sanction, the types of medications used changed from foreign and injectable (Desferal and Exjade) to Iranian medication (Osvral), but serum ferritin levels did not change significantly. Conclusions: During the economic sanctions, the use of Iranian oral iron repellent drugs could reduce the health system's budget for the annual cost of treating thalassemia major patients.
Keyword: Economic sanctions, Drugs, Major Thalassemia.
DOI: https://doi.org/10.31838/ijpr/2020.12.03.073
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free